发明名称 |
Compositions and methods for inactivating or suppressing inflammatory cells |
摘要 |
Methods are provided for reducing the activity or function of an inflammatory cell by contacting a cell with, or administering to a subject in need thereof, an effective amount of a circumsporozoite protein or homolog thereof, or a fragment thereof. Methods of treating an inflammatory disease, or an autoimmune disease or for inducing tolerance are also disclosed as are pharmaceutical compositions comprising a therapeutically effective amount of a circumsporozoite protein or homolog thereof, or a fragment thereof and a pharmaceutically acceptable carrier. |
申请公布号 |
US8865657(B2) |
申请公布日期 |
2014.10.21 |
申请号 |
US200611506611 |
申请日期 |
2006.08.18 |
申请人 |
New York University |
发明人 |
Frevert Ute;Usynin Ivan |
分类号 |
A61K38/10;A61K38/16;A61K39/015;A61K39/00;A61K38/00 |
主分类号 |
A61K38/10 |
代理机构 |
Klauber & Jackson LLC |
代理人 |
Klauber & Jackson LLC |
主权项 |
1. A method for reducing Kupffer cell-mediated inflammation in the liver of a subject suffering from an inflammatory liver disease or disorder associated with Kupffer cell activation by suppressing Kupffer cell activation comprising the steps of:
a) obtaining an isolated and substantially purified circumsporozoite protein (CSP) of a Plasmodium species selected from P. falciparum, P. vivax, P. malariae, P. berghei and P. Yoelii, and comprising any of SEQ ID NOS: 2, 4, 14, 16 or 18, or a fragment thereof comprising the Region I and Region II-plus motifs thereof as set out in SEQ ID NOS: 21-30 and 31-40; b) administering the CSP, or the fragment thereof of (a) in an amount that suppresses Kupffer cell activation to a subject in need thereof; and c) monitoring the subject for reduced inflammation by measuring blood levels of liver enzymes; wherein the subject exhibits elevated liver enzymes and wherein reducing Kupffer-cell mediated inflammation in the subject with the CSP, or the fragment thereof results in normalizing liver enzyme levels. |
地址 |
New York NY US |